Fred Hutch Bone Marrow Transplant Program at SCCA
Doctors at the Fred Hutch Bone Marrow Transplant Program at Seattle Cancer Care Alliance (SCCA) have performed more than 14,000 bone marrow transplants—more than any other institution in the world.
Most Experienced Transplant Center
Clinical use of bone marrow transplantation was first developed at Fred Hutch more than 40 years ago, under the direction of E. Donnall Thomas, MD, who won the Nobel Prize in 1990 for his groundbreaking transplant work. The diseases we treat most often with transplants are lymphoma, multiple myeloma, and acute myelogenous leukemia. We are also advancing the use of transplants for other cancers, bone marrow deficiencies, inborn errors of metabolism, and immune disorders. Read about the transplant process and what to expect when you have a transplant here.
Ranked Among the Best
The Fred Hutch Bone Marrow Transplant Program at SCCA is one of 13 centers whose patients achieved higher-than-expected survival rates. This is according to the most recent multi-year study by the Center for International Blood and Marrow Transplant Research (CIBMTR). The CIBMTR compared patients at 168 bone marrow transplant centers in the United States. Even people who have not found a matched donor may receive treatment here using a cord blood transplant or a haploidentical transplant.
Access to the Latest Research
Hutch doctors and researchers have pioneered many transplant advances, including:
- Less-toxic reduced-intensity transplants (also called non-myeloablative transplants) for older people or those with multiple health problems
- Cord blood transplants and haploidentical transplants, which open up the pool of potential donors
- Transplants to treat a wider array of diseases
- Reduction of post-transplant complications, like graft-versus-host disease, leading to improvements in long-term survival
Our team has well-developed clinical studies available for people who need any type of transplant.